ETON ▲ +1.6% - Eton Pharmaceuticals, Inc.
$ETON - Eton Pharmaceuticals Announces Licensing and Initiation of ET-900 Program Evaluating Mecasermin/IGF-1 for Treatment of Infantile and Epileptic Spasms
02-NOV-2026 06:50 AM ET
Share this post
More filings for $ETON
ETON ▲ +1.6% - Eton Pharmaceuticals, Inc.Nov 2, 2026ETON ▲ +0.9% - Eton Pharmaceuticals, Inc.Oct 29, 2026ETON ▼ -0.4% - Eton Pharmaceuticals, Inc.Aug 27, 2026$ETON SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 28, 2026
View full $ETON filing history →💬 Comments
Loading comments…
Leave a comment